Chad R Marion1,2, Manuel Izquierdo1, Holly C Hanes3, Christopher Barrios4. 1. Department of Internal Medicine, Section on Pulmonary and Critical Care Medicine, Wake Forest Baptist Hospital, Winston-Salem, NC, USA. 2. Department of Internal Medicine, Section on Pulmonary, Critical Care and Sleep Medicine, W. G. (Bill) Hefner Veterans Affairs Medical Center, Salisbury, NC, USA. 3. Department of Pediatrics, Section on Pulmonary Medicine, Wake Forest Baptist Hospital, Winston-Salem, NC, USA. 4. Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, Saint Louis University School of Medicine, St. Louis, MO, USA. Christopher.barrios@health.slu.edu.
Abstract
PURPOSE OF REVIEW: Cystic fibrosis (CF) is a multisystem, autosomal recessive disease that leads to progressive loss of lung function. Respiratory symptoms for both CF and asthma include cough, wheezing, and dyspnea. There is debate within the CF community on how to best define and distinguish CF-asthma overlap syndrome (CFAOS) from asthma-like features, though CFAOS is well-recognized. We aim to review the epidemiology, diagnosis, and treatment of asthma in CF and explore areas where further research is needed. RECENT FINDINGS: There has been considerable improvement in the understanding and treatment of asthma over the past two decades leading to novel therapies such as biologic agents that target the airway inflammation in asthmatics based on their asthma phenotype. These therapies are being studied in CFAOS and are promising treatments. This review provides a comprehensive overview of the definition, epidemiology, diagnosis, and current treatment of CFAOS.
PURPOSE OF REVIEW: Cystic fibrosis (CF) is a multisystem, autosomal recessive disease that leads to progressive loss of lung function. Respiratory symptoms for both CF and asthma include cough, wheezing, and dyspnea. There is debate within the CF community on how to best define and distinguish CF-asthma overlap syndrome (CFAOS) from asthma-like features, though CFAOS is well-recognized. We aim to review the epidemiology, diagnosis, and treatment of asthma in CF and explore areas where further research is needed. RECENT FINDINGS: There has been considerable improvement in the understanding and treatment of asthma over the past two decades leading to novel therapies such as biologic agents that target the airway inflammation in asthmatics based on their asthma phenotype. These therapies are being studied in CFAOS and are promising treatments. This review provides a comprehensive overview of the definition, epidemiology, diagnosis, and current treatment of CFAOS.
Authors: Clement L Ren; Michael W Konstan; Margaret Rosenfeld; David J Pasta; Stefanie J Millar; Wayne J Morgan Journal: Pediatr Pulmonol Date: 2013-10-01
Authors: W J Morgan; S M Butler; C A Johnson; A A Colin; S C FitzSimmons; D E Geller; M W Konstan; M J Light; H R Rabin; W E Regelmann; D V Schidlow; D C Stokes; M E Wohl; H Kaplowitz; M M Wyatt; S Stryker Journal: Pediatr Pulmonol Date: 1999-10
Authors: Ryan J Adam; Katherine B Hisert; Jonathan D Dodd; Brenda Grogan; Janice L Launspach; Janel K Barnes; Charles G Gallagher; Jered P Sieren; Thomas J Gross; Anthony J Fischer; Joseph E Cavanaugh; Eric A Hoffman; Pradeep K Singh; Michael J Welsh; Edward F McKone; David A Stoltz Journal: JCI Insight Date: 2016-04-07
Authors: Peter J Mogayzel; Edward T Naureckas; Karen A Robinson; Gary Mueller; Denis Hadjiliadis; Jeffrey B Hoag; Lisa Lubsch; Leslie Hazle; Kathy Sabadosa; Bruce Marshall Journal: Am J Respir Crit Care Med Date: 2013-04-01 Impact factor: 21.405
Authors: Philip M Farrell; Terry B White; Clement L Ren; Sarah E Hempstead; Frank Accurso; Nico Derichs; Michelle Howenstine; Susanna A McColley; Michael Rock; Margaret Rosenfeld; Isabelle Sermet-Gaudelus; Kevin W Southern; Bruce C Marshall; Patrick R Sosnay Journal: J Pediatr Date: 2017-02 Impact factor: 4.406
Authors: Brian D Kent; Stephen J Lane; Edwin J van Beek; Jonathan D Dodd; Richard W Costello; Harm A W M Tiddens Journal: Pediatr Pulmonol Date: 2014-01-13
Authors: Nick Shrine; Michael A Portelli; Catherine John; María Soler Artigas; Neil Bennett; Robert Hall; Jon Lewis; Amanda P Henry; Charlotte K Billington; Azaz Ahmad; Richard J Packer; Dominick Shaw; Zara E K Pogson; Andrew Fogarty; Tricia M McKeever; Amisha Singapuri; Liam G Heaney; Adel H Mansur; Rekha Chaudhuri; Neil C Thomson; John W Holloway; Gabrielle A Lockett; Peter H Howarth; Ratko Djukanovic; Jenny Hankinson; Robert Niven; Angela Simpson; Kian Fan Chung; Peter J Sterk; John D Blakey; Ian M Adcock; Sile Hu; Yike Guo; Maen Obeidat; Don D Sin; Maarten van den Berge; David C Nickle; Yohan Bossé; Martin D Tobin; Ian P Hall; Christopher E Brightling; Louise V Wain; Ian Sayers Journal: Lancet Respir Med Date: 2018-12-11 Impact factor: 30.700